CIK 0001674416 · Large accelerated filer
CRISPR Therapeutics AG
Sign in to watch- Ticker
- CRSP
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- Switzerland
- Entity type
- operating
- EIN
- 473173478
- Phone
- 6173154600
- Business address
- BAARERSTRASSE 14, ZUG, Switzerland
- Former names
- CRISPR Therapeutics AG
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $4,881,673
- in 7 filings, $1.5M under 10b5-1 plans
Net −$4,881,673. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-03-14 | Kulkarni Samarth Chief Executive Officer | Option exercise | +20,625 | 256,183 | ||
| 2026-03-14 | Kulkarni Samarth Chief Executive Officer | Option exercise · Restricted Stock Units | −20,625 | 61,875 | ||
| 2026-03-11 | KASINGER JAMES R. General Counsel and Secretary | Sale | −2,800 | $52.80 | $148K | 87,815 |
| 2026-03-11 | Kulkarni Samarth Chief Executive Officer | Sale | −9,798 | $52.80 | $517K | 235,558 |
| 2026-03-10 | KASINGER JAMES R. General Counsel and Secretary | Option exercise | +5,500 | 90,615 | ||
| 2026-03-10 | KASINGER JAMES R. General Counsel and Secretary | Option exercise · Restricted Stock Units | −5,500 | 5,500 | ||
| 2026-03-10 | Kulkarni Samarth Chief Executive Officer | Option exercise | +19,250 | 245,356 | ||
| 2026-03-10 | Kulkarni Samarth Chief Executive Officer | Option exercise · Restricted Stock Units | −19,250 | 19,250 | ||
| 2026-02-19 | Kulkarni Samarth Chief Executive Officer | Sale | −6,967 | $52.58 | $366K | 226,106 |
| 2026-02-19 | KASINGER JAMES R. General Counsel and Secretary | Sale | −2,112 | $52.58 | $111K | 85,115 |
| 2026-02-18 | Kulkarni Samarth Chief Executive Officer | Option exercise | +13,250 | 233,073 | ||
| 2026-02-18 | Kulkarni Samarth Chief Executive Officer | Option exercise · Restricted Stock Units | −13,250 | 0 | ||
| 2026-02-18 | KASINGER JAMES R. General Counsel and Secretary | Option exercise | +3,825 | 87,227 | ||
| 2026-02-18 | KASINGER JAMES R. General Counsel and Secretary | Option exercise · Restricted Stock Units | −3,825 | 0 | ||
| 2026-01-22 | Prasad Raju Chief Financial Officer | Option exercise 10b5-1 | +34,972 | $45.15 | $1.6M | 41,739 |
| 2026-01-22 | Prasad Raju Chief Financial Officer | Sale 10b5-1 | −34,972 | $60.19 | $2.1M | 6,767 |
| 2026-01-22 | Prasad Raju Chief Financial Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −34,972 | 41,667 | ||
| 2026-01-22 | Kulkarni Samarth Chief Executive Officer | Sale 10b5-1 | −60,000 | $60.23 | $3.6M | 134,201 |
| 2026-01-20 | Kulkarni Samarth Chief Executive Officer | Sale 10b5-1 | −21,433 | $51.61 | $1.1M | 202,768 |
| 2026-01-20 | Kulkarni Samarth Chief Executive Officer | Sale 10b5-1 | −8,567 | $52.10 | $446K | 194,201 |
Page 5 of 46 · 910 trades